FDA Drug Application (019516) for MS CONTIN by PURDUE PHARMA LP

Back to FDA Applications sponsored by PURDUE PHARMA LP

Application Number019516
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMS CONTIN
Active IngredientMORPHINE SULFATE

Active IngredientCount
List of drugs with Active Ingredient MORPHINE SULFATE11


Back to FDA Applications sponsored by PURDUE PHARMA LP